ROELMI HPC is more than glad to welcome you in Rotterdam, from May 20th to March 22nd at the 6Th edition of Microbiome R&D and Business Collaboration Forum, the networking event where discover the latest scientific & technological advances in microbiome & probiotics research, and discover which commercialization strategies deliver.
Part of the leading global microbiome and probiotics conference series, the 2019 European event will bring together more than 300 industries, academic, and investment leaders to discuss the most cutting-edge microbiome and probiotics research, challenges and opportunities in moving research towards commercialization, and potential partnerships and collaborations.
For the first time, this event will be three days.
Discover our research about multiple approaches to innovate microbiome knowledge and rebalancing
Microbiome is today a hot topic for health and personal care market. Healthy status of people is often link to the homeostasis of microbiome populating different body districts, meaning that specific microorganisms like bacteria, fungi and viruses colonize different sites of our body, by creating complex but balanced living communities.
Recent studies have highlighted the link between those localized microbiome dysbiosis (prevalence of pathogens on the skin compared to the healthy microbiota composition) and inflammatory or allergic diseases (for example atopic dermatitis or acne).
ROELMI HPC, starting from its deep knowledge of probiotics, has developed different approaches to interact with localized microbiomes. First, by investigating secondary effects of probiotics on the gut-brain-skin axis and second by exploring cutting-edge technologies for a new era of ingredients application on microbiome.
With a strong basis on bio-fermentation, ROELMI HPC discovered how to protect probiotics and make them more suitable for food application by encapsulation technology, in order to preserve them during product preparation and administration. Later, the activity of probiotics has been investigated not only within the intestine, but also by looking at their effect on skin inflammation, on cognitive function, in metabolic pathways, in the urogenital system, etc. As a step forward, ROELMI HPC moved to a different market, from nutraceutical to cosmetics, designing specific ingredients for the skin. First by using deactivated probiotics thanks to their booster and immune-mimetic effect, then by developing ingredients aiming to rebalance the skin microbiome affected by external stresses like air pollution or salty/chlorinated water.
Every new development has been studied in vivo by looking at the metagenomics of microbiomes and skin improvement by specific parameters measurement. Volunteers belonging to both European and Asian ethnicities have been selected to globally enlarge ROELMI HPC expertise on this leading-edge topic.